Melatonin Orifarm

Melatonin, the active ingredient in Melatonin Orifarm, is a melatonin receptor agonist presented as an oral dosage form for oral use. It is used to treat insomnia and other sleep‑wake rhythm disorders in adults, helping to regulate circadian timing and promote natural sleep onset.

GNH USA supplies Melatonin Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing and regulatory‑aligned distribution for sleep‑care products. The company adheres to stringent quality standards and offers flexible packaging options to meet diverse market requirements.

Melatonin Orifarm is a melatonin receptor agonist used to address disorders of the sleep‑wake cycle. - Insomnia: facilitates sleep onset and maintenance in individuals experiencing difficulty falling or staying asleep. - Delayed Sleep Phase Disorder: helps advance circadian timing, allowing earlier sleep onset for those with a shifted sleep pattern. - Jet Lag: reduces the time needed to adjust to new time zones by synchronizing the internal clock.

Melatonin Orifarm may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Drowsiness: feeling of sleepiness during the day. - Headache: mild to moderate head pain. - Dizziness: sensation of light‑headedness or imbalance. - Nausea: mild stomach upset. - Vivid dreams: unusually intense or memorable dreams.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Mood changes: depression or increased anxiety. - Hormonal effects: alterations in reproductive hormone levels. - Cardiovascular events: rare cases of palpitations or blood pressure changes.

When considering Melatonin Orifarm, several precautionary measures should be observed to ensure safe use. - Pregnancy: safety has not been established; use only if clearly needed. - Breastfeeding: potential transfer to infant; evaluate risk versus benefit. - Concomitant CNS depressants: may enhance sedative effects; monitor patient. - Underlying medical conditions: assess for depression, seizure disorders, or autoimmune disease before use. - Age considerations: use with caution in elderly patients due to increased sensitivity. - Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture and light.

Melatonin Orifarm can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase bleeding risk. - Immunosuppressants (e.g., cyclosporine): potential reduction in drug effectiveness. - Sedatives (e.g., benzodiazepines, barbiturates): additive CNS depression.

Moderate Interactions (Monitor Closely): - Antihypertensives: melatonin may lower blood pressure modestly. - Oral contraceptives: possible alteration of hormone levels. - Antidepressants (SSRIs, SNRIs): may increase risk of serotonin syndrome. - Caffeine: can diminish melatonin’s sleep‑promoting effect.